Search - tctmd.com

Displaying 61 - 80 of 4798

Sort: Relevancy | Date

Presentation TCT 2016

Is LAA Closure an Alternative to Triple Therapy for all Patients or Those at High Bleeding Risk? Current Dataset

Presenter: Martin W. Bergmann, Samir R. Kapadia, Brian K. Whisenant

November 01, 2016

Presentation TCT 2016

Choose a Drug-Eluting Stent: Heres Why

Presenter: George D. Dangas, Fabio Felice Tarantino, Carlo Cernetti

November 01, 2016

Presentation TCT 2016

Case Introduction: What Device(s) to Choose in a Patient With NSTE-ACS?

Presenter: George D. Dangas, Fabio Felice Tarantino, Massimo Fineschi

November 01, 2016

Presentation TCT 2016

Case Presentation: Complex PCI in STEMI and Cardiogenic Shock

Presenter: Bagrat Alekyan, Grzegorz L. Kaluza, Vladimir Ganyukov

November 01, 2016

Presentation TCT 2016

Why Triple Therapy? Rationale and Potential Role for LAA Closure in the PCI Patient

Presenter: Martin W. Bergmann, Samir R. Kapadia, Ashish Pershad

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: ILUMIEN III: OPTIMIZE PCI and COLOR

Presenter: Giulio Guagliumi, Ik-Kyung Jang, Ron Waksman

November 01, 2016

Presentation TCT 2016

Risks of Antegrade CTO PCI: Lessons From Registry Data and Personal Experience

Presenter: Christopher E. Buller, Masahisa Yamane, Kambis Mashayekhi

November 01, 2016

Presentation TCT 2016

Stroke Interventions: Parallels to Primary PCI for Acute MI and the Potential Role of the Cardiologist

Presenter: D. Christopher Metzger, Bernhard Reimers

November 01, 2016

Presentation TCT 2016

Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment in NSTE-ACS

Presenter: Roxana Mehran, Ferdinando Varbella, Dominick J. Angiolillo

November 01, 2016

Presentation TCT 2016

PASCAR: Global Hearts Sub-Saharan Africa PCI Capacity Survey Results

Presenter: Jack C. Lewin, Hugh J. Linnehan, Habib Gamra

November 01, 2016

Presentation TCT 2016

Risks of Retrograde CTO PCI: Lessons From Registry Data and Personal Experience

Presenter: Christopher E. Buller, Masahisa Yamane, Emmanouil S. Brilakis

November 01, 2016

Presentation TCT 2016

The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status

Presenter: Freek W.A. Verheugt, Pascal Vranckx, Deepak L. Bhatt

November 01, 2016

Presentation TCT 2016

The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI: Design, Rationale, and Status

Presenter: Freek W.A. Verheugt, Pascal Vranckx, Roxana Mehran

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) from: EXCEL and NOBLE

Presenter: Yves R. Louvard, John D. Puskas, Davide Capodanno

November 01, 2016

Presentation TCT 2016

TCT 259: Coronary Artery Perforation During Percutaneous Coronary Intervention: Incidence and Outcomes

Presenter: Mauricio G. Cohen, Bernhard Witzenbichler

November 01, 2016

Presentation TCT 2016

The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status

Presenter: Freek W.A. Verheugt, Pascal Vranckx

November 01, 2016

Presentation TCT 2016

TCT 252: The Incidence, Determinants and Outcomes of Coronary Perforation During Percutaneous Coronary Intervention in the United Kingdom Between 20062013: an analysis of 527,121 Cases from the British Cardiovascular Intervention Society Database

Presenter: Mauricio G. Cohen, Bernhard Witzenbichler

November 01, 2016

Presentation TCT 2016

The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status

Presenter: Freek W.A. Verheugt, Pascal Vranckx, C. Michael Gibson

November 01, 2016

Presentation TCT 2016

TCT 251: Non-procedural Predictors of Stroke After Percutaneous Coronary Intervention

Presenter: Mauricio G. Cohen, Bernhard Witzenbichler

November 01, 2016

News Industry News TCT 2016

Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI

November 01, 2016

Advertisement

Is LAA Closure an Alternative to Triple Therapy for all Patients or Those at High Bleeding Risk? Current Dataset

Choose a Drug-Eluting Stent: Heres Why

Case Introduction: What Device(s) to Choose in a Patient With NSTE-ACS?

Case Presentation: Complex PCI in STEMI and Cardiogenic Shock

Why Triple Therapy? Rationale and Potential Role for LAA Closure in the PCI Patient

Highlights (and my Interpretations) From: ILUMIEN III: OPTIMIZE PCI and COLOR

Risks of Antegrade CTO PCI: Lessons From Registry Data and Personal Experience

Stroke Interventions: Parallels to Primary PCI for Acute MI and the Potential Role of the Cardiologist

Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment in NSTE-ACS

PASCAR: Global Hearts Sub-Saharan Africa PCI Capacity Survey Results

Risks of Retrograde CTO PCI: Lessons From Registry Data and Personal Experience

The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status

The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI: Design, Rationale, and Status

Highlights (and my Interpretations) from: EXCEL and NOBLE

TCT 259: Coronary Artery Perforation During Percutaneous Coronary Intervention: Incidence and Outcomes

The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status

TCT 252: The Incidence, Determinants and Outcomes of Coronary Perforation During Percutaneous Coronary Intervention in the United Kingdom Between 20062013: an analysis of 527,121 Cases from the British Cardiovascular Intervention Society Database

The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status

TCT 251: Non-procedural Predictors of Stroke After Percutaneous Coronary Intervention

Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content